Dynavax Technologies Corp DVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
11.03UNCH (UNCH)
Volume
51,643
Close
11.03quote price arrow up+0.30 (+2.80%)
Volume
2,331,152
52 week range
10.48 - 15.15
Loading...
  • Open10.74
  • Day High11.06
  • Day Low10.60
  • Prev Close10.73
  • 52 Week High15.15
  • 52 Week High Date11/03/23
  • 52 Week Low10.48
  • 52 Week Low Date05/09/24

Key Stats

  • Market Cap1.443B
  • Shares Out130.86M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-21.1

KEY STATS

  • Open10.74
  • Day High11.06
  • Day Low10.60
  • Prev Close10.73
  • 52 Week High15.15
  • 52 Week High Date11/03/23
  • 52 Week Low10.48
  • 52 Week Low Date05/09/24
  • Market Cap1.443B
  • Shares Out130.86M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-21.1

RATIOS/PROFITABILITY

  • EPS (TTM)0.05
  • P/E (TTM)221.04
  • Fwd P/E (NTM)70.71
  • EBITDA (TTM)-16.63M
  • ROE (TTM)1.56%
  • Revenue (TTM)236.149M
  • Gross Margin (TTM)80.34%
  • Net Margin (TTM)3.91%
  • Debt To Equity (MRQ)36.05%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dynavax Technologies Corp

 

Profile

MORE
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company, which is engaged in developing and commercializing vaccines. The Company's products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. It also manufactures and...
Scott Myers
Independent Chairman of the Board
Ryan Spencer
Chief Executive Officer, Interim Chief Financial Officer, Director
David Novack
President, Chief Operating Officer
Address
2100 Powell Street, Suite 720
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
ADMA
ADMA Biologics Inc
8.79-0.02-0.23%
ZLAB
Zai Lab Ltd
21.52+1.44+7.17%
MIRM
Mirum Pharmaceuticals Inc
24.78+0.02+0.08%
PTGX
Protagonist Therapeutics Inc
29.32+1.09+3.86%
DNA
Ginkgo Bioworks
0.8407+0.0798+10.4876%